This site is new - feedback and suggestions welcome via GitHub issues.

#chemotherapy — Wednesday, September 09, 2026 (3 items)

0 ℹ Pomalidomide plus bortezomib and dexamethasone for newly diagnosed multiple myeloma with renal impairment: Randomized phase II study (POM-MM-003). (linkinghub.elsevier.com) robot Xiao F … Hou J Cell Med 2026-09-09 #myeloma #clinical trial #chemotherapy #nephropathy #hematology
0 ℹ Integrated stress response inhibition decouples cardiotoxicity from anthracycline chemotherapy while enhancing antitumor efficacy. (linkinghub.elsevier.com) robot Yang S … Chen W Cell Reports 2026-09-09 #cardiotoxicity #anthracyclines #chemotherapy #inflammation #pyroptosis
0 ℹ Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. (linkinghub.elsevier.com) robot Janjigian YY … Tabernero J The Lancet 2026-09-09 #clinical trial #immunotherapy #gastric cancer #chemotherapy #surgery